Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Dogodan Therapeutics Logo
Dogodan Therapeutics CB Rank
833750
Heat Score
63
Dogodan Therapeutics provides genomic medicines for lung infections and respiratory diseases.
Founded
obfuscation
Private Westford, Massachusetts, United States1-10 www.dogodan.com/
Pharmaceutical
Overview

Dogodan Therapeutics
Heat Score
63

Growth Score
pts
in past quarter
Heat Score 63
-14 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Dogodan Therapeutics

CB Rank
833750
Dogodan Therapeutics provides genomic medicines for lung infections and respiratory diseases.
Founded
obfuscation
Private Westford, Massachusetts, United States1-10 www.dogodan.com/
Pharmaceutical

Key People

  • Photo of Thomas T Tibbitts
    Thomas T Tibbitts: Chief Executive Officer
    Past Role: Goldfinch Biopharma, SVP Computational Discovery

Details

Legal Name Dogodan Therapeutics, Inc
Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Research & Development

Dogodan Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 1

Employee Profiles

News

News and Press

News•Oct 30, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 29, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$165.5KThis year, Dogodan Therapeutics is projected to spend $165.5K on IT, according to Aberdeen.

Active Website Tech Count

4Dogodan Therapeutics is actively using 4 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, CommonCrawl Top 50m, and  Euro.

Total IP

2The intellectual property of Dogodan Therapeutics includes 2 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Dogodan Therapeutics's headquarters? Dogodan Therapeutics is located in Westford, Massachusetts, United States.Who are Dogodan Therapeutics's competitors? Alternatives and possible competitors to Dogodan Therapeutics may include Verve Therapeutics, Intellia Therapeutics, and  Editas Medicine.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|